Wave 80 Biosciences Inc MD, based in San Francisco, specializes in developing and improving homogeneous assays that address clinical needs by detecting probes and targets entirely in the solution phase. Their innovative Infra technology focuses on sample preparation challenges in molecular testing, ensuring the recovery of low-concentration target analytes in complex matrices like sputum.
With a focus on solving difficult assay development problems, Wave 80's technology and expertise offer solutions for issues such as low target analyte concentrations, unfavorable kinetics, and poor binding epitope availability. Their capabilities span across various areas in human health and disease, from infectious diseases to autoimmune disorders, aiming to improve patient outcomes through advanced bioassay technologies and products.
Generated from the website